Delivery Order SPE2DB22D2009-SPE2DB23FM3QJ
Award Date 8/28/23
Potential Completion Date 8/29/23
Potential Value $6.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill agency requirements between August 24-25, 2023. No subcontractors or set aside designations were indicated. The award is consistent with DLA's mission to provide medical supplies...
- The Defense Logistics Agency awarded a $26,862 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML under a firm fixed price contract. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 21, 2023 to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The delivery order was awarded against an...
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 15, 2023 in support of DLA's medical supply procurement programs. As a leading pharmaceutical distributor, Amerisourcebergen will deliver the requested pharmaceutical product without use of subcontractors. The delivery order was awarded under an...
- The Defense Logistics Agency awarded a $7,007.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The order is for the delivery of this pharmaceutical product to a location in Conshohocken, Pennsylvania by September 26, 2023 in support of DLA programs. Amerisourcebergen will serve as the prime contractor on this small order under an existing DLA-wide supply chain management contract vehicle from which various medical supplies and medications...
- The Defense Logistics Agency awarded a $29,579.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements between August 8-9, 2023. As a leading provider of medical supplies to the Department of Defense, DLA relies on contracts such as this to ensure troops have access...
- The Defense Logistics Agency awarded a $76,911 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a firm fixed price contract executed from August 8-9, 2023 in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The DLA manages the Department of Defense's global logistics operations and supply chain to support military readiness....
- The Defense Logistics Agency awarded a $100,735.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the STELARA syringes to a facility in Conshohocken, Pennsylvania by September 28, 2023. No subcontractors or set aside designations were identified. This...
- The Defense Logistics Agency awarded a $37,535 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. As the prime contractor, Amerisourcebergen will provide the pharmaceutical products to the DLA under a firm fixed price contract set to be completed by July 28, 2023. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the United...
- The Defense Logistics Agency awarded a $29,171.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 28, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from July 14 to July 17, 2023. No subcontractors or set aside designations were identified. This delivery order supports...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM3QJDelivery Order
The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 29, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the United States military and this order for an immunosuppressive drug falls within its mandate to procure medical supplies and equipment for the armed forces.
Generated 12/24/23, 8:55 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/28/23 |